SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cook Medical’s Ongoing Zilver® PTX® Trial Data Show Higher Freedom From Target Lesion Revascularization (TLR) Rates Compared to Angioplasty and Bare Metal Stenting After Three Years